Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis. - Robin C; Rollot F; Lefort M; Casey R; Vukusic S; Mathey G; Ciron J; De Seze J; Stankoff B; Maillart E; Ruet A; Labauge PM; et al. (Neurology, 2025)